Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
about
Phase I study of simultaneous dose escalation and schedule acceleration of cyclophosphamide-doxorubicin-etoposide using granulocyte colony-stimulating factor with or without antimicrobial prophylaxis in patients with small-cell lung cancer.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Phase I study of simultaneous ...... s with small-cell lung cancer.
@ast
Phase I study of simultaneous ...... s with small-cell lung cancer.
@en
type
label
Phase I study of simultaneous ...... s with small-cell lung cancer.
@ast
Phase I study of simultaneous ...... s with small-cell lung cancer.
@en
prefLabel
Phase I study of simultaneous ...... s with small-cell lung cancer.
@ast
Phase I study of simultaneous ...... s with small-cell lung cancer.
@en
P2093
P2860
P356
P1476
Phase I study of simultaneous ...... s with small-cell lung cancer.
@en
P2093
Ardizzoni A
Mariani GL
Pennucci MC
Venturini M
P2860
P2888
P304
P356
10.1038/BJC.1996.504
P407
P577
1996-10-01T00:00:00Z